Casein Kinase 2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014167)
◆英語タイトル:Casein Kinase 2 Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014167
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Casein Kinase 2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Casein Kinase 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Casein Kinase 2 Inhibitors. This report provides information on the therapeutic development based on the Casein Kinase 2 Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Casein Kinase 2 Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Casein Kinase 2 Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Casein Kinase 2 Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for Casein Kinase 2 Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Casein Kinase 2 Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• Casein Kinase 2 Inhibitors Overview
• Casein Kinase 2 Inhibitors Disease Associated
• Casein Kinase 2 Inhibitors Pipeline Therapeutics
• Casein Kinase 2 Inhibitors Therapeutics under Development by Companies
• Casein Kinase 2 Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Casein Kinase 2 Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Casein Kinase 2 Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Casein Kinase 2 Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Casein Kinase 2 Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Casein Kinase 2 Inhibitors – Discontinued Products
• Casein Kinase 2 Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Casein Kinase 2 Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Casein Kinase 2 Inhibitors by Therapy Area, 2014
• Number of Products under Development for Casein Kinase 2 Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Casein Kinase 2 Inhibitors Assessment by Monotherapy Products
• Casein Kinase 2 Inhibitors Assessment by Combination Products
• Casein Kinase 2 Inhibitors Assessment by Route of Administration
• Casein Kinase 2 Inhibitors Assessment by Stage and Route of Administration
• Casein Kinase 2 Inhibitors Assessment by Molecule Type
• Casein Kinase 2 Inhibitors Assessment by Stage and Molecule Type
• Casein Kinase 2 Inhibitors Therapeutics – Discontinued Products
• Casein Kinase 2 Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for Casein Kinase 2 Inhibitors by Therapy Area, 2014
• Number of Products under Development for Casein Kinase 2 Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Casein Kinase 2 Inhibitors Assessment by Monotherapy Products
• Casein Kinase 2 Inhibitors Assessment by Combination Products
• Casein Kinase 2 Inhibitors Assessment by Route of Administration
• Casein Kinase 2 Inhibitors Assessment by Stage and Route of Administration
• Casein Kinase 2 Inhibitors Assessment by Molecule Type
• Casein Kinase 2 Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 耐火積層ガラスの世界市場2021
    Notes:Production, means the output of Laminated Fire Resistant Glass Revenue, means the sales value of Laminated Fire Resistant Glass This report studies Laminated Fire Resistant Glass in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manuf …
  • ヘビーデューティートラックの世界市場予測2018-2023
    Heavy-duty (HD) trucks come under heavy-duty commercial vehicles and are used for cargo transportation, logistics operations, construction, mining, and agricultural fields for various functions. Heavy Duty (HD) Truck is the largest trucks allowed on the road, it is mostly used for long-haul purposes …
  • スリランカのフットウェア市場(~2019)
    The report Footwear Market in Sri Lanka to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for footwear in Sri Lanka. The research includes historic data from 2008 to 2014 and forecasts until 2019 which makes …
  • ティーウェイホールディングス(Tway Holdings Incorporation)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • ヘキサフルオロプロピレン(HFP)の世界市場2015
    Hexafluoropropylene(HFP) (CAS 116-15-4) Market Research Report 2015 aims at providing comprehensive data on Hexafluoropropylene(HFP) market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Hexafluoropropylene(HFP) description, covers its application areas …
  • ビニルアセテートエチレンエマルジョン(VAE)の世界市場
    Vinyl Acetate-Ethylene Emulsions (VAE) Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries …
  • 複合微生物肥料の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Composite Microbial Fertilizer Revenue, means the sales value of Composite Microbial Fertilizer This report studies sales (consumption) of Composite Microbial Fertilizer in Global market, especially in United States, China, Europe and Japan, focuses on top play …
  • PARI Pharma GmbH :企業製品パイプライン分析2013(ヘルスケア市場レポート)
    PARI Pharma GmbH - Product Pipeline Review - 2013 Summary Global Market Direct’s pharmaceuticals report, “PARI Pharma GmbH - Product Pipeline Review - 2013” provides data on the PARI Pharma GmbH’s research and development focus. The report includes information on current developmental pipeline, comp …
  • 建設用骨材のコロンビア市場
    This report is the result of Timetric’s extensive market research covering the construction aggregates market in Colombia. It contains detailed historic and forecast market value data for the aggregates market and its categories (construction sands, gravel & pebbles, crushed stone, chippings (marble …
  • 世界主要国におけるクラウドコンピューティング市場2017-2022
    The Global Cloud Computing market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Cloud Computing in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014167 )"Casein Kinase 2 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:Casein Kinase 2 Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。